Ahead of this weekend's Super Bowl, some good news for the athletes: NFL players are largely avoiding opioid-based pain ...

Anesthesia remains a dynamic industry as leaders explore new methods of opioid-free pain management and expand into new care settings. Christina Menor, MD, president-elect of the California Society of ...

We welcome O’Ryan and colleagues’ introspective tone and call for a “global conversation” on academia’s role in healthcare.1 Their article resonates with our thoughts and experiences in pain ...

High bilirubin levels increase the risk of developing bilirubin gallstones—a type of gallstone more prevalent in Sickle Cell ...

Patients treated with platinum-based agents and taxanes had the highest prevalence of chronic painful chemotherapy-induced peripheral neuropathy, researchers found.

Many patients face delays in receiving support due to gaps between primary and specialized care. Collaborative programs ...

Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

For the first time in 20 years, the Food and Drug Administration has approved a new pharmaceutical approach to treating pain.